Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw ...

While RSV isn’t any more virulent than the cold, flu or COVID, the same precautions are recommended in order to control its ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.

Generally, healthcare providers will diagnose HMPV based on your symptoms, taking into account your medical history. A swab ...

Dr. Gabriela Andujar Vazquez, with Dartmouth Health, is answering viewer questions as winter illnesses continue to spread.

But the percentage of people testing positive for HMPV out of those visiting participating GPs with symptoms of respiratory ...

Respiratory Syncytial Virus (RSV) is a highly contagious respiratory illness that primarily affects infants and older adults, ...

Respiratory Syncytial Virus, or RSV, has dominated headlines with an influx of cases across the country and here in Western ...

ST. PAUL — Statewide data released Thursday, Jan. 23, by the Minnesota Department of Health indicates that hospitalizations ...

With a recent surge in influenza, COVID-19, norovirus, respiratory syncytial virus (RSV), and other respiratory viruses, it's ...